Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer-Reference-Cited by-同舟云学术

Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer

Published:2020-08-31 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Khoury Katia,Tan Antoinette R.,Elliott Andrew,Xiu Joanne,Gatalica Zoran,Heeke Arielle L.,Isaacs Claudine,Pohlmann Paula R.,Schwartzberg Lee S.,Simon Michael,Korn W. Michael,Swain Sandra M.,Lynce Filipa

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference45 articles.

1. Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer;Avivar-Valderas;Oncotarget.,2018

2. PTEN function in normal and neoplastic growth;Chow;Cancer Lett.,2006

3. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis;Cully;Nat Rev Cancer.,2006

4. Cellular function of phosphoinositide 3-kinases: implications for development, immunity, homeostasis, and cancer;Katso;Annu Rev Cell Dev Biol.,2001

5. PIK3CA somatic mutations in breast cancer: mechanistic insights from langevin dynamics simulations;Mankoo;Proteins.,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors;Frontiers in Oncology;2024-07-12

2. Different Oncogenes and Reproductive Histories Shape the Progression of Distinct Premalignant Clones in Multistage Mouse Breast Cancer Models;The American Journal of Pathology;2024-07

3. The Association of PTEN Gene Mutations with the Breast Cancer Risk: A Systematic Review and Meta-analysis;Biochemical Genetics;2023-09-02

4. Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors;2023-07-18

5. Genomic Signatures from Clinical Tumor Sequencing in Patients with Breast Cancer Having Germline BRCA1/2 Mutation;Cancer Research and Treatment;2023-01-15